Maravai LifeSciences Holdings Inc reports results for the quarter ended in June - Earnings Summary

Maravai Lifesciences Holdings

04/08/2022 23:32

* Maravai LifeSciences Holdings Inc  MRVI.OQ  reported
quarterly
adjusted earnings of 54 cents​​ per share for the quarter ended
in June. The mean expectation of nine analysts for the quarter
was for earnings of 45 cents per share.
    * Revenue rose 11.5% to $242.73 million from a year ago;
analysts
expected $233.24 million. 
    * Maravai LifeSciences Holdings Inc's reported EPS for the
quarter
was 53 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.1%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Maravai LifeSciences Holdings Inc shares had fallen
by 7.4% this
quarter and lost 37.2% so far this year.
    * The company reported quarterly net income of $71.24
million.
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $42.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 4
at 10:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      0.45           0.54           Beat
 Mar. 31 2022      0.44           0.54           Beat
 Dec. 31 2021      0.38           0.45           Beat
 Sep. 30 2021      0.35           0.44           Beat